U.S. House lawmakers have warned Attorney General Merrick Garland about the impact of Teva Pharmaceuticals agreeing to provide Texas, Florida and Rhode Island with more than $220 million worth of naloxone. The lawmakers believe this will alter innovation in the current market of medication-assisted treatment and naloxone. Read more here.